Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Fate specification triggers a positive feedback loop of TEAD-YAP and NANOG to promote epiblast formation in preimplantation embryos

Epiblast formation by Tead-Yap-dependent expression of pluripotency factors and competitive elimination of unspecified cells

Transcriptional regulatory networks in epiblast cells and during anterior neural plate development as modeled in epiblast stem cells

NANOG initiates epiblast fate through the coordination of pluripotency genes expression

Blastocoel expansion and AMOT degradation cooperatively promote YAP nuclear localization during epiblast formation

NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers

Extensive co-binding and rapid redistribution of NANOG and GATA6 during emergence of divergent lineages

The transcription factor GABPA is a master regulator of naive pluripotency

Lineage regulators TFAP2C and NR5A2 function as bipotency activators in totipotent embryos

TEAD2 initiates ground-state pluripotency by mediating chromatin looping

HIPPO Pathway Members Restrict SOX2 to the Inner Cell Mass Where It Promotes ICM Fates in the Mouse Blastocyst

Epigenomic Analysis of Gastrulation Identifies a Unique Chromatin State for Primed Pluripotency

Multiple phases in regulation of Nanog expression during pre-implantation development

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Cross-regulation of the Nanog and Cdx2 Promoters

PI3K/AKT signaling controls ICM maturation and proper epiblast and primitive endoderm specification in mice

The transcripts of a gastrula-premarked enhancer prime posterior tissue development through cross-talk with morphogen effector

ADNP modulates SINE B2-derived CTCF-binding sites during blastocyst formation in mice

Control of ground-state pluripotency by allelic regulation of Nanog

NANOG expression in parthenogenetic porcine blastocysts is required for intact lineage specification and pluripotency

Transcriptional network governing extraembryonic endoderm cell fate choice